ICU MEDICAL INC/DE

For the period ended Mar 31, 2026. Filed May 7, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 7, 2026

ICUI$182.11+1.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets at and

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value data and treasury shares)

March 31,2026 · December 31,2025
	(Unaudited)	(1)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$288,330		$307,963
Accounts receivable, net of allowance for doubtful accounts $14,744 at March 31, 2026 and $14,383 at December 31, 2025	201,077		180,515
Inventories	605,590		615,859
Prepaid expenses and other current assets	118,248		86,217
TOTAL CURRENT ASSETS	1,213,245		1,190,554
PROPERTY, PLANT AND EQUIPMENT, net	445,135		451,817
OPERATING LEASE RIGHT-OF-USE ASSETS	50,792		54,470
GOODWILL	1,485,561		1,499,754
INTANGIBLE ASSETS, net	598,968		633,559
DEFERRED INCOME TAXES	25,648		25,891
OTHER ASSETS	63,496		62,877
INVESTMENTS IN UNCONSOLIDATED AFFILIATES	130,918		131,586
TOTAL ASSETS	$4,013,763		$4,050,508
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable	$173,982		$154,374
Accrued liabilities	314,570		315,337
Current portion of long-term debt	18,750		18,750
Income tax payable	10,602		10,400
TOTAL CURRENT LIABILITIES	517,904		498,861
LONG-TERM DEBT	1,261,826		1,265,917
OTHER LONG-TERM LIABILITIES	82,333		89,536
DEFERRED INCOME TAXES	14,514		37,756
INCOME TAX LIABILITY	25,258		34,613
COMMITMENTS AND CONTINGENCIES (Note 20)
STOCKHOLDERS’ EQUITY:
Convertible preferred stock, $1.00 par value; Authorized — 500 shares; Issued and outstanding — none	—		—
Common stock, $0.10 par value; Authorized — 80,000 shares; Issued — 25,186 shares at March 31, 2026 and 24,688 shares at December 31, 2025; and outstanding — 24,993 shares at March 31, 2026 and 24,688 shares at December 31, 2025	2,519		2,469
Additional paid-in capital	1,465,467		1,465,118
Treasury stock, at cost (193,046 shares at March 31, 2026 and 172 shares at December 31, 2025)	(25,183)		(22)
Retained earnings	721,022		690,890
Accumulated other comprehensive loss	(51,897)		(34,630)
TOTAL STOCKHOLDERS' EQUITY	2,111,928		2,123,825
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$4,013,763		$4,050,508

(1)December 31, 2025 balances were derived from audited consolidated financial statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.